Healthcare entity
All 2 tracked stories fall under one category: market-trends. Weiss Ratings is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The 40-day window averages about 0.4 stories each week. Their average consequence score of 5 runs below the beat's 6 for that window.
Last mentioned: Aug 17, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: market-trends. Weiss Ratings is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The 40-day window averages about 0.4 stories each week. Their average consequence score of 5 runs below the beat's 6 for that window. They are less corroborated than the beat average, carrying 3 original sources each against 3.6 for the same window. Geode Capital Management LLC appears in 2 tracked Healthcare stories published from July 5, 2026 through August 13, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 372 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Geode Capital Management LLC. Shared-story counts are live from our verified record — not editorial picks.
Ensysce Biosciences short interest soared 619.9% to 364,278 shares as its stock trades at $0.30, while Focus Universal posted just $0.05M in quarterly revenue. The data highlights severe financial fragility across two small healthcare and device innovators.
A major Shuttle Pharmaceuticals shareholder just poured $110,694 into the beaten-down stock, buying 32,591 shares at near all-time lows. For healthcare investors, this insider vote of confidence in a radiation oncology developer could signal upcoming clinical catalysts or a potential turnaround.
Geode Capital Management LLC is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
